News and Announcements
Altech Chemicals Board Appointments Update
- Published October 23, 2015 4:00PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
23rd October 2015, ASX Announcement
Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to advise that it has appointed His Royal Highness Price Ya’cob Bin Tunku Tan Sri Abdullhah, as a non-executive director to Altech Chemicals Limited Board, and that the Price has nominated Mr Uwe Ahrens as his alternate.
ABOUT ALTECH CHEMICALS
Altech Chemicals Limited is aiming to become one of the world’s leading suppliers of a high-value product, 99.99% (4N) high purity alumina (HPA) (Al2O3). HPA is the major source material for scratch-resistant artificial sapphire glass, which is used in the next generation of smartphones as well as a growing range of high performance electronic applications such as LED’s, semi-conductors, and phosphor TV screens. The global HPA market is approximately 19,040tpa and is expected to double over the coming decade.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
